Project Grant HT94252510941
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$1.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
The University of Wisconsin System was awarded a $1,074,650 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from September 1, 2025 to August 31, 2029, will fund research to investigate the immunomodulatory effects of chemokine signaling in renal cell carcinoma. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by addressing...
The University of Wisconsin System was awarded a $777,500 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective June 1, 2025 through May 31, 2028, will support a multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative...
The University of Wisconsin System was awarded a $1,555,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from April 15, 2025 to April 14, 2029, will support research to develop population modeling techniques aimed at optimizing equitable ovarian cancer outcomes. This work aligns with the program's focus on transforming healthcare for military service members, veterans, and the broader public through...
The University of Wisconsin System has been awarded a $516,366 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from September 1, 2024 to August 31, 2027, will fund research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. This research initiative aims to transform healthcare for military service members and the broader...
The University of Wisconsin System was awarded a $729,778 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a 3-year research project titled "Multiomic Analysis of Liquid Biopsies for Biomarker Discovery and Therapeutic Targeting". The research aims to advance biomedical capabilities for the military and public by leveraging innovative multiomic analysis of liquid biopsies to identify novel...
This federal Project Grant award of $1,251,230.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a breast cancer research project with the University of Wisconsin System. The award will fund a clinical trial focused on breakthrough breast cancer treatments, with a performance period from June 2025 to June 2029. The University of Wisconsin System, a leading public research institution, will serve as the primary awardee and perform the...
The University of Wisconsin System was awarded a $500,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program by the Defense Health Agency. The grant supports the delivery of a novel immune inhibitory transgene to vascular composite allografts during normothermic preservation, with the goal of decreasing rejection after transplantation. The 2-year project, running from August 1, 2025 to July 31, 2027, aims to transform healthcare for military service...
The University of Wisconsin System was awarded a $995,076 project grant by the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of new agents for the treatment of hormone receptor positive and HER2 positive breast cancer. The grant was awarded on Dec 15, 2023 and is scheduled for completion on Dec 14, 2026. As part of this project, the University of Wisconsin System has sub-awarded funding to Loyola University of...
The University of Wisconsin-Madison will receive $1.17 million over four years through a Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research to interrogate the intersection of prostate-specific membrane antigen and PI3K pathway signaling as a novel treatment approach for treatment-resistant prostate cancer. The University will investigate medical solutions for prostate cancer with the goals of transforming patient...
This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...